Palmitoylethanolamide ( PEA ) Induces an Increase in Spleen Regulatory T Cells, Reduces CD8 + Cells and TNF ‐α Levels in Target Organs, and Protects Mice From Graft‐Versus‐Host Disease‐Related Mortality Through PPAR Activation Without Compromising the Graft‐Versus‐Tumour Response
Immunology · 2025-11 · 176 (3) · 385-402
DOI: 10.1111/imm.70010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology, online erschienen am 25.06.2025. Verfasst von Bárbara Betônico Berg und 9 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program in Biological Sciences: Physiology and Pharmacology, Federal University of Minas Gerais, Belo Horizonte, Brazil. Hauptthemen laut MEDLINE: Ethanolamines, Palmitic Acids, Graft vs Host Disease, CD8-Positive T-Lymphocytes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação de Amparo à Pesquisa do Estado de Minas Gerais, Pró-Reitoria de Pesquisa, Universidade Federal de Minas Gerais.
Abstract (Originalsprache)
Graft‐versus‐host disease (GVHD), a secondary complication of bone marrow transplantation, leads to the development of a systemic inflammatory illness in the host, resulting in high mortality and morbidity. Current therapies lack prophylactic effectiveness and often fail to achieve an optimal immunological balance between inflammation and immunosuppression. In this study, we investigated the effects of palmitoylethanolamide (PEA), an endocannabinoid‐like lipid mediator with extensively documented anti‐inflammatory, analgesic, antimicrobial, immunomodulatory, and neuroprotective effects, on the complex pathology of GVHD. Treatment with PEA reduced clinical disease severity in GVHD mice, leading to an 80% increase in survival rates. Additionally, PEA created an immunoregulatory environment in the spleen by reducing the activation of CD3 + CD4 + cells. In the intestine, PEA protected against damage, reduced the number of CD3 + CD4 + and CD3 + CD8 + cells, and suppressed the activation of CD3 + CD8 + cells. PEA also decreased the levels of TNF‐α in the intestine and increased IL‐10 production. Furthermore, in the liver, PEA treatment reduced the number of CD8 + cells, the activation of CD3 + CD4 + and CD3 + CD8 + cells, and TNF‐α levels. The effect of PEA on survival was dependent on Peroxisome Proliferator‐activated receptor gamma (PPAR‐γ) activation but did not rely on cannabinoid (CB) receptors activation. In addition to GVHD protection, PEA treatment did not interfere in the graft‐versus‐tumour response. These results demonstrate the therapeutic potential of PEA as a promising option for the treatment of GVHD, balancing inflammation and immunosuppression, and improving both survival and clinical outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Program in Biological Sciences: Physiology and Pharmacology, Federal University of Minas Gerais, Belo Horizonte, Brazil.
- Department of Nursing, School of Nursing, Federal University of Minas Gerais, Belo Horizonte, Brazil.
- Department of Pharmacology, Federal University of Minas Gerais, Belo Horizonte, Brazil.
- Department of Biochemistry and Immunology, Federal University of Minas Gerais, Belo Horizonte, Brazil.
- Department of Morphology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Brazil.
ORCID-Profile: Zara Desiree Tonidandel Campos, Marina Gomes Miranda Castor
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais
- Pró-Reitoria de Pesquisa, Universidade Federal de Minas Gerais
Zitieren
APA
Berg, B. B., Campos, Z. D. T., Ruggio, G. M. F., Linhares, A. F. S., Rezende, B. M., de Assis Cau, S. B., Romero, T. R. L., Teixeira, M. M., Pinho, V., & Miranda Castor, M. G. (2025). Palmitoylethanolamide ( PEA ) Induces an Increase in Spleen Regulatory T Cells, Reduces CD8 + Cells and TNF ‐α Levels in Target Organs, and Protects Mice From Graft‐Versus‐Host Disease‐Related Mortality Through PPAR Activation Without Compromising the Graft‐Versus‐Tumour Response. Immunology, 176(3), 385-402. https://doi.org/10.1111/imm.70010
Vancouver
Berg BB, Campos ZDT, Ruggio GMF, Linhares AFS, Rezende BM, de Assis Cau SB, et al. Palmitoylethanolamide ( PEA ) Induces an Increase in Spleen Regulatory T Cells, Reduces CD8 + Cells and TNF ‐α Levels in Target Organs, and Protects Mice From Graft‐Versus‐Host Disease‐Related Mortality Through PPAR Activation Without Compromising the Graft‐Versus‐Tumour Response. Immunology. 2025;176(3):385-402. doi:10.1111/imm.70010
BibTeX
@article{Berg2025,
author = {Berg, Bárbara Betônico and Campos, Zara Desiree Tonidandel and Ruggio, Gioconda Muniz Fiorenza and Linhares, Ana Flávia Santos and Rezende, Bárbara Maximino and de Assis Cau, Stêfany Bruno and Romero, Thiago Roberto Lima and Teixeira, Mauro Martins and Pinho, Vanessa and Miranda Castor, Marina Gomes},
title = {Palmitoylethanolamide ( PEA ) Induces an Increase in Spleen Regulatory T Cells, Reduces CD8 + Cells and TNF ‐α Levels in Target Organs, and Protects Mice From Graft‐Versus‐Host Disease‐Related Mortality Through PPAR Activation Without Compromising the Graft‐Versus‐Tumour Response},
journal = {Immunology},
year = {2025},
volume = {176},
number = {3},
pages = {385--402},
doi = {10.1111/imm.70010}
}
EUVIMED